28488744 Myxedema Coma

Embed Size (px)

Citation preview

  • 7/28/2019 28488744 Myxedema Coma

    1/14

    MYXEDEMA COMA

  • 7/28/2019 28488744 Myxedema Coma

    2/14

    MYEDEMA COMA

    End stage of untreated or insufficiently treated hypothyroidism

    Typical clinical picture: Elderly obese female

    Becoming increasingly withdrawn, lethargic, sleepy and confused

    Slips into a coma

    History: Previous thyroid surgery

    Radioiodine

    Default thyroid hormone therapy

  • 7/28/2019 28488744 Myxedema Coma

    3/14

    Precipitating Events

    Cerebrovascular accidents

    Myocardial infarction

    Infection UTI

    Pneumonia

    Gastrointestinal hemorrhage

    Acute trauma Administration of sedative, narcotics, tranquilizers,

    potent diuretics

    CCF

  • 7/28/2019 28488744 Myxedema Coma

    4/14

    Pathogenesis of Myxedema coma

  • 7/28/2019 28488744 Myxedema Coma

    5/14

    Symptoms

    Cold intolerance, dry skin

    Constipation, weight gain, poor appetite

    Neurological-weakness, slow speech,disorientation ,apathy, psychosis

    Symptoms progress to lethargy, disorientation,

    grandmal seizures, coma

  • 7/28/2019 28488744 Myxedema Coma

    6/14

    Physical Findings

    Comatose or semi comatose

    Dry coarse skin, cold peripheries

    Puffy face, hands, feet

    Bradycardia

    Delayed reflex relaxation time

    Hypothermia, hypotension,hypoventillation

    Pericardial, pleural effusions, ascites

    GI ileus, urinary retention

  • 7/28/2019 28488744 Myxedema Coma

    7/14

    Lab Findings

    Free T4-low and TSH-high

    If TSH-low/N and FT4-low, consider central orpitutary hypothyroidism.

    Blood gases-hypoxemia, hypercapnia, acidosis

    Hypoglycemia, hyponatremia

    Blood culture, urine culture, CXR

    ECG

    LFT,RFT Distinguish from euthyroid sick syndrome

    Low T3, Normal or low TSH, normal free T4

  • 7/28/2019 28488744 Myxedema Coma

    8/14

    Management of Myxedema coma

    ICU admission is required for

    ventilatory support, continuousclose monitoring of pulmonary and

    cardiac status

    IV medications

  • 7/28/2019 28488744 Myxedema Coma

    9/14

    General & supportive

    1. ABC

    2. IV access-large bore 18 guage

    3. Fluid replacement

    isotonic crystalloid solutions like NS/RL

    Avoid hypotonic solutions

    Avoid vasopressors-risk of dysrythmia

    4. Treatment of hypothermia-corrected once T4is administered

  • 7/28/2019 28488744 Myxedema Coma

    10/14

    Treatment of hypoglycemia -50% Dextrose

    initially. Then 5%Dextrose infusion in NS/RL

    Glucocorticoids-Hydrocortisone Na

    phosphate/succinate 100mg every 8hrs for

    48hrs.Then taper over 1 week

    Treat the precipitating cause

  • 7/28/2019 28488744 Myxedema Coma

    11/14

    Specific Therapy

    Parenteral thyroxine

    Loading dose of 200500 g T4, IVover 1 hr

    Then 50-100 g daily until oral intake

    is tolerated

    Controversy exists as to whether to give T3,

    in addition to T4

  • 7/28/2019 28488744 Myxedema Coma

    12/14

    Treatment

    Hypothyroidism

    Hypocortisolemia

    Hypoventillation

    Hypothermia

    Hyponatremia

    Hypotension

    Hypoglycemia

    IV 200-500 g loading doseT4.Then 50-100 g

    IV hydrocortisone 100mg8hrly

    Intubation, mechanicalventilation

    Blankets, no active methods

    Cautious fluid replacement

    Volume expansion-crystalloids

    Dextrose

  • 7/28/2019 28488744 Myxedema Coma

    13/14

    Prognosis

    When recognized & treated early, mortality is

    15-20%, and is mostly due to underlying and

    precipitating diseases.

    If not recognized early, mortality is 60-70%,

    especially in elderly.

  • 7/28/2019 28488744 Myxedema Coma

    14/14

    Thank you